scispace - formally typeset
H

Harm W.J. van Marwijk

Researcher at Brighton and Sussex Medical School

Publications -  257
Citations -  24109

Harm W.J. van Marwijk is an academic researcher from Brighton and Sussex Medical School. The author has contributed to research in topics: Anxiety & Randomized controlled trial. The author has an hindex of 54, co-authored 252 publications receiving 22213 citations. Previous affiliations of Harm W.J. van Marwijk include VU University Medical Center & University of Amsterdam.

Papers
More filters
Journal ArticleDOI

Pharmacological interventions for somatoform disorders in adults.

TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI

Depression and the risk for cardiovascular diseases: systematic review and meta analysis

TL;DR: Depression and cardiovascular diseases are both common among elderly and depression is suspected to be an independent risk factor for the onset of coronary heart disease, yet it is not clear to what extent and if depression also is associated with the start of other diseases of the circulatory system.
Journal ArticleDOI

Controlled Interventions to Reduce Burnout in Physicians A Systematic Review and Meta-analysis

TL;DR: Evidence from this meta-analysis suggests that recent intervention programs for burnout in physicians were associated with small benefits that may be boosted by adoption of organization-directed approaches, providing support for the view that burnout is a problem of the whole health care organization, rather than individuals.
Journal ArticleDOI

Patients' preferences in the treatment of depressive disorder in primary care

TL;DR: It can be concluded that a substantial percentage of well-informed patients prefer psychotherapy, and patients with strong preferences, mostly for Psychotherapy, are likely not to enter antidepressant treatment or randomized clinical trials if their preferences are not supported.